All News about Beigene Ltd ADR
Will Investors Notice Exciting Sign On BeiGene's Chart?
December 06, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
UK's NICE Recommends BeiGene's Cancer Drug For Rare Form Of Blood Cancer
September 20, 2022
Via Benzinga
![]() ![]() ![]() ![]()
BeiGene Announces Brazil Approvals for BRUKINSA® As a Treatment for Rare Blood Cancers
November 10, 2022
From BeiGene
Via Business Wire
![]() ![]()
BeiGene Reports Third Quarter 2022 Financial Results
November 09, 2022
From BeiGene, Ltd.
Via Business Wire
![]()
BeiGene to Present at Upcoming Investor Conferences
November 04, 2022
From BeiGene
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
October 13, 2022
Via Benzinga
![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|